A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
Daniel Goran, Product Manager at Bruker, gives us a behind-the-scenes look at the new eWARP EBSD system. Here, he explains how the new design meets the needs of researchers with its advanced optics ...
Cerro de Pasco Resources consolidates technical, environmental, and permitting work for Quiulacocha in Peru – and provides ...
A preliminary WNW–ESE radon trend interpreted at Bardy is considered consistent with regional dyke orientations reported by Québec government geologists (MRNF SIGEOM database). NIOB is integrating ...
Interim safety and efficacy data to be reported in Q1VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Processa ...
Objectives Older adults can have difficulties understanding and recalling information prior to hospitalisation for elective treatment. Limited research exists regarding how older adults perceive the ...
In power distribution systems, three-phase transformer configuration directly impacts system reliability and load management.
Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...
Combining microscopy and machine-learning techniques leads to faster, more precise analyses of critical coating materials ...
Habitat loss and degradation remain the most significant threats, fragmenting the areas where wildlife once roamed freely ...
Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more about RZLT stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback